Invention Application
- Patent Title: IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE
-
Application No.: US17484628Application Date: 2021-09-24
-
Publication No.: US20220089570A1Publication Date: 2022-03-24
- Inventor: Andrew P. CREW , Craig M. CREWS , Hanqing DONG , Meizhong JIN , Yimin QIAN , Jing WANG
- Applicant: Arvinas Operations, Inc.
- Applicant Address: US CT New Haven
- Assignee: Arvinas Operations, Inc.
- Current Assignee: Arvinas Operations, Inc.
- Current Assignee Address: US CT New Haven
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C12N9/12 ; C12N9/18 ; A61K45/06 ; C12Q1/25 ; A61K31/4439 ; A61K31/519 ; A61K31/513 ; A61K47/54 ; A61K47/66

Abstract:
The description relates to imide-based compounds, including bifunctional compounds comprising the same, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins which are degraded and/or otherwise inhibited by bifunctional compounds according to the present invention. In particular, the description provides compounds, which contain on one end a ligand which binds to the cereblon E3 ubiquitin ligase and on the other end a moiety which binds a target protein such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. Compounds can be synthesized that exhibit a broad range of pharmacological activities consistent with the degradation/inhibition of targeted polypeptides of nearly any type.
Information query